Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEXRAZOXANE FOR INJECTION safely and effectively. See full prescribing information for DEXRAZOXANE FOR INJECTION. DEXRAZOXANE for injection, for intravenous use Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
Dexrazoxane for injection is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m2 and who will continue to receive doxorubicin therapy to maintain tumor control. Do not use with the initiation of doxorubicin therapy [see Warnings and Precautions (5.2)].
- generic_name
- dexrazoxane
- brand_name
- SODIUM LACTATE
- product_names
- DEXRAZOXANE, SODIUM LACTATE
- ndc
- 55150-434, 55150-437, 55150-434-01, 55150-432, 55150-432-01, 55150-433, 55150-433-01, 55150-437-01, 55150-435, 55150-435-01, 55150-436, 55150-436-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en